Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY: LH )

227.10 -1.17 (-0.51%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 641,442
Open 229.50
Bid (Size) 222.15 (1)
Ask (Size) 233.72 (1)
Prev. Close 228.27
Today's Range 227.08 - 231.51
52wk Range 191.97 - 239.50
Shares Outstanding 83,700,000
Dividend Yield 1.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
Via Benzinga
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather. 
Via Benzinga
Topics Earnings
Exposures Financial

Performance

YTD
-2.35%
-2.35%
1 Month
+5.59%
+5.59%
3 Month
-0.64%
-0.64%
6 Month
+12.96%
+12.96%
1 Year
+8.03%
+8.03%

More News

Read More
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Via Benzinga
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
From NOWDiagnostics, Inc.
Via Business Wire
Analyst Ratings For Labcorp Holdings
Via Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Via Benzinga
Analyst Expectations For Labcorp Holdings's Future
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Via Benzinga
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
Via Benzinga
Is This Telehealth Stock a Buy After the Recent Pullback?
Via MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Analyst Ratings For Laboratory Corp
Via Benzinga
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Via Benzinga
Laboratory Corp's Ex-Dividend Date Is Monday, Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
From Xcell Biosciences Inc.
Via Business Wire
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Via Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
Via MarketBeat
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
Via Benzinga
Laboratory Corp. of America Holdings (NYSE: LH) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.